Your ending paragraph says it all at this time, imo.
Ocata is only barely at it's 6.00+ price because it's being relentlessly primarily manipulated at this price level, coupled with a few foolish premature individuals buying shares.
Ocata has to be going lower when we really get told when/where funding's coming from. Then, after momentary excitement,sanity will set in and the share price 'dike' will break one of these days, creating further fear on the part of investors.
One needs to ask themselves why after all this time since Lancet release, we've just go down bigtime, why the so called 'smart money' isn't rushing in to buy and why the share price isn't zillions of dollars higher?
The answer imo, is individuals have gotten totally carried away by the early sketchy developing Ocata science and the so called 'smart money' knows the company has miles and miles of clinicals and millions and millions of funding, and then the FDA to go.
Translation, all degrading the viability of Ocata as an INVESTMENT now.
News 
Market Data 
Discover 
